Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Favorite
Like
Tweet
Print
Akshanth Polepally, PhD
Director
AbbVie Inc
Poster(s):
030: Drug-Drug Interaction of Celecoxib With Navitoclax in Subjects With Myeloproliferative Neoplasms (MPN)
Sunday, September 10, 2023
5:00 PM - 7:00 PM
PT
083: Pharmacokinetics & Safety of Navitoclax in Hepatic Impairment
Sunday, September 10, 2023
5:00 PM - 7:00 PM
PT